Cadrenal Therapeutics, Inc. (CVKD)
$0.91-2.15%Close
SELLCRISIS · day 108
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 1.84
- P/E (TTM)
- -0.20
- Short % float
- 4.34%
- Days to cover
- 1.1
- SI change
- -10.8%
- 1W
- -3.19%
- 1M
- -22.88%
- vs SPY 1W
- -4.35%
- vs SPY 1M
- -25.87%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CVKD?
- LOPJLB’s latest quantitative signal on Cadrenal Therapeutics, Inc. Common Stock (CVKD) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CVKD in?
- Cadrenal Therapeutics, Inc. Common Stock (CVKD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Cadrenal Therapeutics, Inc. Common Stock (CVKD) do?
- Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease an…